JOURNAL of
ONCOLOGICAL
SCIENCES

Year 2018 - Volume 4 - Issue 3
Original research article ::.

  • Experience from Turkish centers participating in the Early Access Program (EAP): Preliminary real-world safety data of nivolumab (nivo) combined with ipilimumab (ipi) in pre-treated advanced melanoma patients a Health Sciences University, Gulhane Training and Research Hospital, Department of Medical Oncology, Ankara, Turkey b Ankara Yıldırım Beyazıt University, Faculty of Medicine, Department of Medical Oncology, Ankara, Turkey c Ege University, Faculty of Medicine, Department of Medical Oncology, Izmir, Turkey d Medipol Mega Hospitals Complex, Faculty of Medicine, Department of Medical Oncology, Istanbul, Turkey e Sakarya University, Faculty of Medicine, Department of Medical Oncology, Sakarya, Turkey f Akdeniz University, Faculty of Medicine, Department of Medical Oncology, Antalya, Turkey g Pamukkale University, Faculty of Medicine, Department of Medical Oncology, Denizli, Turkey h Ondokuz Mayıs University, Faculty of Medicine, Department of Medical Oncology, Samsun, Turkey i Hacettepe University Cancer Institute, Department of Medical Oncology, Ankara, Turkey j Baskent University Faculty of Medicine, Department of Medical Oncology, Adana, Turkey k Medical Science Liaison, Bristol Myers Squib, Istanbul, Turkey l Istanbul Cerrahpasa University, Faculty of Medicine, Department of Medical Oncology, Istanbul, Turkey m Dicle University, Faculty of Medicine, Department of Medical Oncology, Diyarbakır, Turkey n MarmaraUniversity, Faculty of Medicine, Department of Medical Oncology, Istanbul, Turkey oUniversity of Health Sciences, Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital, Department of Medical Oncology, Ankara, Turkey p Medical Park Tarsus Hospital, Department of Medical Oncology, Mersin, Turkey qMedical Park Samsun Hospital, Department of Medical Oncology, Samsun, Turkey rGazi University, Faculty of Medicine, Department of Medical Oncology, Ankara, Turkey sAcıbadem University, Faculty of Medicine, Department of Medical Oncology, Istanbul, Turkey DOI: 10.1016/j.jons.2018.10.001 Pages: 125 - 129 1365 Viewed.

  • Risk factors for thrombosis risk in patients with cancer aAnkara University School of Medicine, Department of Internal Medicine, Ankara, Turkey bAnkara University School of Medicine, Department of Medical Oncology, Ankara, Turkey cKastamonu State Hospital, Department of Medical Oncology, Kastamomu, Turkey DOI: 10.1016/j.jons.2018.09.001 Pages: 130 - 133 1231 Viewed.

Review article ::.
  • Cytokine release syndrome a Kayseri Education and Research Hospital, Hematology Department, Kayseri, Turkey b Erciyes University, Faculty of Medicine, Hematology Department, Kayseri, Turkey DOI: 10.1016/j.jons.2018.09.002 Pages: 134 - 141 1421 Viewed.


Case report ::.